瑞科生物－Ｂ：2024年報.pdf

1、 (a joint stock company incorporated in the Peoples Republic of China with limited liability)Stock Code 股份代號:2179江蘇瑞科生物技術股份有限公司Jiangsu Recbio Technology Co.,Ltd.ANNUAL REPORT2024年報（於中華人民共和國註冊成立的股份有限公司）2Corporate Information公司資料6Chairmans Statement主席致辭9Financial Highlights財務摘要10Management Discussion

2、and Analysis管理層討論與分析40Biographies of Directors,Supervisors and Senior Management董事、監事及高級管理層履歷61Directors Report董事會報告107Corporate Governance Report企業管治報告134Independent Auditors Report獨立核數師報告143Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表144Consolidated Statement

3、 of Financial Position綜合財務狀況表146Consolidated Statement of Changes in Equity綜合權益變動表148Consolidated Statement of Cash Flows綜合現金流量表150Notes to Financial Statements財務報表附註254Definitions and Glossary of Technical Terms釋義及技術詞彙Contents目錄2Jiangsu Recbio Technology Co.,Ltd.江蘇瑞科生物技術股份有限公司Corporate Information公

4、司資料DIRECTORS1Executive DirectorsDr.LIU Yong(Chairman of the Board and General Manager)Mr.LI BuMs.CHEN QingqingDr.HONG KunxueNon-executive DirectorsDr.WANG RuweiDr.ZHANG JiaxinDr.ZHOU HongbinMr.HU HouweiIndependent Non-executive DirectorsDr.XIA LijunMr.LIANG GuodongProfessor GAO FengProfessor YUEN Mi

5、ng FaiSUPERVISORS2Ms.QIAO Weiwei(Chairwoman)Mr.WANG FeizhouMs.QIAN RantingMs.LIU Ping1 Dr.LIU Yong,Mr.LI Bu,Ms.CHEN Qingqing and Dr.HONG Kunxue were appointed as executive Directors of the second session of the Board on May 8,2024;Dr.WANG Ruwei,Dr.ZHANG Jiaxin,Dr.ZHOU Hongbin and Mr.HU Houwei were a

6、ppointed as non-executive Directors of the second session of the Board on May 8,2024;Dr.XIA Lijun,Mr.LIANG Guodong,Professor GAO Feng and Professor YUEN Ming Fai were appointed as independent non-executive Directors of the second session of the Board on May 8,2024;Dr.LIU Yong was elected as the chai